Abstract-HIV patients on highly active antiretroviral therapy (HAART) exhibit elevated incidence of cardiovascular disease (CVD), including a higher risk of myocardial infarction and prevalence of atherosclerotic lesions, as well as increases in markers of subclinical atherosclerosis including increased carotid artery intima-media thickness (c-IMT), increased arterial stiffness, and impaired flow-mediated dilation. Both HAART and HIV-infection are independent risk factors for atherosclerosis and myocardial infarction. Studies implicate the HIV proteins tat, gp120, vpu, and nef in early on-set atherosclerosis. The objective of this study was to quantify the role of expression of HIV-1 proteins on the vascular function, biomechanics, and geometry of common carotid arteries and aortas. This study employed NL4-3D gag/pol transgenic mice (HIV-Tg), which contain the genetic sequence for the HIV-1 proteins env, tat, nef, rev, vif, vpr, and vpu but lacks the gag and pol genes and reports that HIV-Tg mice have impaired aortic endothelial function, increased c-IMT, and increased arterial stiffness. Further, HIV-Tg arteries show decreased elastin content, increased cathepsin K and cathepsin S activity, and increased mechanical residual stress. Thus, mice that express HIV proteins exhibit preclinical markers of atherosclerosis and these markers correlate with changes in markers of vascular remodeling. These findings are consistent with the hypothesis that HIV-proteins, independent of HAART treatment or HIV infection, could play a role in of the development of CVD.
INTRODUCTION
Human immunodeficiency virus-1 (HIV-1) affects over 34 million people worldwide. 46 Due to the success of highly active antiretroviral therapy (HAART), HIV-1-infection has been transformed from a terminal diagnosis to a manageable chronic disease. HIV patients, however, have elevated incidence of dyslipidemia, lipodystrophy, insulin resistance, diabetes mellitus, and cardiovascular disease (CVD); the latter includes an elevated risk of myocardial infarction 6, 9, 26 and higher prevalence of atherosclerotic lesions, 16, 25, 29 as well as increases in markers of subclinical atherosclerosis, including increased carotid artery intima-media thickness (c-IMT), 12, 14, 28, 30, 31, 47 increased arterial stiffness, 3, 36, 47 and impaired brachial artery flow-mediated dilation (FMD), an indicator of endothelial dysfunction. 2, 3, 11, 13, 31, 43, 45, 47 HAART drugs, particularly protease inhibitors, 10, 11, 37, 38, 49 but also other drug classes, 4, 13, 23, 54 are often implicated as a mediator of early on-set CVD. Data, however, also suggest that HIV, independent of HAART, can induce CVD. 7, 12, 31 Elevated c-IMT and impaired FMD have been observed in HIV positive/ HAART naı¨ve patients. 31 Exposure of endothelial cells in vitro to various HIV proteins decreases nitric oxide (NO) synthase and increases cell adhesion molecules, endothelial permeability, cell proliferation, cytokine signaling, apoptosis, and oxidative stress 18, 32, 33 ; these mechanisms are all implicated in the development of atherosclerosis. However, there remains a need to investigate the effect of the viral proteins, independent of viral infection and HAART, on the vasculature in an in vivo model.
The purpose of this study was to determine the effects of HIV-1 proteins on endothelial function, intima-media thickness, and arterial stiffness in common carotid arteries and aortas in the NL4-3D gag/pol transgenic mouse (HIV-Tg). This is a non-infectious model with a 7.4 kb transgene that contains the genetic sequence for the HIV-1 proteins env, tat, nef, rev, vif, vpr, and vpu, but lacks the gag and pol genes and is thus unable to replicate. 19 Additional markers of vascular remodeling were also quantified; namely, collagen and elastin content, collagen fiber orientation, cathepsin activity, residual stress, and axial mechanical behavior of these arteries. Data indicate that common carotid arteries and aortas from HIV-Tg mice exhibited impaired endothelial function and elevated c-IMT and arterial stiffness. These changes were coincident with decreased elastin content, increased protease activity (cathepsins K and S), and increased residual stress in the artery wall, suggesting that vascular remodeling, due in part to synthesis, proteolytic degradation, and remodeling of key structural components of the arterial wall (e.g., elastin and collagen) occurs in parallel to impaired vascular function and plays a role in the observed changes the geometric properties (i.e., c-IMT) and biomechanical properties (e.g., arterial stiffness) of the artery wall. These findings are consistent with the hypothesis that HIV-1 proteins alone, independent of HAART treatment or HIV infection, could play a role in vascular remodeling associated with atherosclerosis.
MATERIALS AND METHODS

HIV-Transgenic Mouse Model
Male hemizygous NL4-3D gag/pol transgenic and wild-type littermate (FVB/N) mice, 10-12 weeks old, were euthanized with CO 2 and the right and left common carotids arteries and the aorta were removed and cleaned free of loose perivascular tissue. Unlike the homozygous HIV-1 Tg mice, which are smaller at birth, have decreased food intake compared to wildtype mice, and usually die within 40 days postnatal, the hemizygous mice appear normal at birth but develop signs of disease as they age, specifically renal failure known as HIV-associated nephropathy. 19 All work was conducted under the regulation of Georgia Institute of Technology's and Atlanta VA Medical Center's Institutional Animal Care and Use Committees (IACUC).
Endothelial Function Testing
The contractile and relaxation properties of the aorta were analyzed as described previously. 41, 42 5-mm long rings from excised aortas, with intact endothelium, were maintained in physiological saline solution (PSS, 118 mM NaCL, 4.73 nM KCl, 1.2 mG MgSO 4 , 0.025 mM EDTA, 1.2 mM KH 2 PO 4 , 2.5 mM CaCl 2 , 11 mM glucose, and 25 mM NaH 2 CO 3 , at a pH of 7.4 when bubbled in 95% O 2 /5% CO 2 at 37°C) and mounted on wire hooks attached to a Harvard Apparatus Differential Capacitor Force Transducer for isometric contraction. The rings were contracted with 300 nM phenylephrine to 80-90% of maximum contraction. The relaxation response of the precontracted rings to actetylcholine (1 nM to 100 lM) and sodium nitroprusside (SNP), a NO donor, (0.1 nM to 1 lM) was determined and recorded as a function of concentration.
Biomechanical Measurements: Cylindrical Biaxial
Testing, Arterial Stiffness, and Opening Angle
Cylindrical Biaxial Testing
Cylindrical biaxial biomechanical tests of arteries were performed as previously described. 52 Excised common carotid arteries and aortas were maintained in culture medium (Dulbecco's modified Eagles medium containing 4.5 g/L glucose and sodium pyruvate without L-glutamine and phenol red, Invitrogen, Inc.). For the aorta, branches within the suprarenal region were ligated using 10-0 silk sutures, and 8-0 suture was used to mount the arteries on two glass cannulae on the custom mechanical testing device. 52 The vessel and cannulae were suspended in a bath on the device, which was filled with media containing SNP to ensure that the arteries were fully dilated during the mechanical tests. Perfusion of the vessel through the two glass cannulae allowed for careful control of the luminal pressure. The mounting cannulae were attached to computer controlled actuators that allowed for precise control of the vessel length, and a force transducer connected to one cannula allowed for the measurement of the axial load imposed on the vessel during testing. Thus, this computer-controlled device had the capability of maintaining precise luminal pressure and axial length of the vessel, while recording the outer diameter and axial force during the testing. All mechanical testing was completed within 2 h following vessel excision.
Following preconditioning, fixed length pressurediameter tests and fixed pressure force-length tests were performed under quasistatic loading conditions. 52 For pressure-diameter tests, vessels were cyclically inflated from 0 to 160 mmHg at a series of fixed axial stretches of k = 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, and 1.9 (k is the loaded vessel length/unloaded vessel length), with three loading/unloading cycles for each axial stretch. During the force-length tests vessels were held at constant pressures of 0, 40, 60, 80, 100, and 120 mmHg and cyclically stretched until a maximum axial load of 1 g (for common carotid arteries) or 3 g (for the aorta) with three loading/unloading cycles at each pressure. Repeatable mechanical loading curves were achieved after preconditioning and three loading cycles, indicating that this protocol achieved adequate preconditioning and that the maximum loads (160 mmHg and 1 g) did not induce mechanical damage.
Arterial Stiffness
The Peterson's modulus E p À Á , a common measure of arterial stiffness, was calculated as the slope of the pressure-outer diameter curve DP=DD ð Þ at a given pressure normalized to the outer diameter D ð Þ at that pressure; namely, E p ¼ DP= DD=D ð Þ.
Opening Angles
Opening angle measurements were taken to quantify the residual stress in the unloaded configuration. 5 A 14% gelatin mixture was injected into the vessel, and a series of segments were cut and placed in phosphate buffered saline (PBS). 50 
Note, that h is the half of the central angle of the stress free sector; thus, the traditional opening angle is 180 2 h. 
Intima-Media Thickness Measurements
The vessel wall thickness was quantified by two methods: two-photon imaging of live arteries mounted on the biomechanical testing device was used to quantify the intima-media thickness and adventitia thickness and standard histology of fixed, sectioned, and stained vessels was used as an additional measure to quantify intima-media thickness.
Two-Photon Microscopy
The custom biomechanical testing device fits on a LSM 510 META inverted confocal microscope (Zeiss) to visualize collagen and elastin, using their autofluorescent properties, across the entire wall of live, unfixed mouse arteries. 52 Isolated vessels, maintained in PSS, were excited with a 800 nm two-photon laser and collagen was visualized by detecting its second harmonic generation around 400 nm, and elastin emissions were detected by setting the META filter to a 480-560 nm bandpass configuration. 55 Z-stacks were collected at a variety of loading conditions including at a pressure of 100 mmHg and the in vivo axial stretch (k = 1.7). Orthogonal views of these z-stacks were then used to calculate the thickness of the adventitial layer (collagen images) and intima-media layer (elastin images) of the arteries.
Histology
Vessels were fixed in 10% buffered formalin under no external loading, immersed in 30% sucrose overnight, embedded in optimal cutting temperature (OCT) medium, and frozen. The arteries were cut into 7 lm thick slices, mounted on slides, and stained with hematoxylin and eosin. The images were analyzed using ImageJ (NIH) to quantify the thickness of the arteries.
Collagen Fiber Organization Measurements
The two-photon microscopy images were also used to quantify the angular distribution of collagen fibers within the arterial wall. The angles of fibers in each slice of the z-stack were quantified using a fast Fourier series algorithm program in a MATLAB script as established previously. 44, 51 Briefly, the initial processing included a low-pass filter, conversion to binary, and windowing with a 2D Tukey window. A fast Fourier transform of the preprocessed image generated a power spectrum. A histogram of the frequency of intensities between 290°and 90°with 4°bins was created from the spectrum. This process was repeated for each slice within the z-stack to generate a distribution of fibers across the wall for each vessel. The thickness and relative wall location were normalized and the corresponding distributions in each vessel were averaged to create a surface which represented the fiber angle distributions through the wall for both groups. The mean mid-wall distribution and weighted mean fiber angle for each group were also calculated and compared.
Collagen and Elastin Content Measurements
Right and left common carotid arteries from a single mouse or a single suprarenal aorta were dried in a vacuum oven at 37°C for 2 days. The dry weight of the vessels was recorded for normalizing to protein content. For collagen analysis, collagen was solublized by placing the vessel in 0.5 mL of 0.5 M acetic acid containing pepsin with a 1:3 ratio of enzyme to tissue weight. The tubes containing the vessels were placed in a 37°C water bath for 48 h with occasional agitation.
Sirius red dye solution (0.3 mg/mL direct 80 Sirius red in 0.5 M acetic acid) was added to each tube and the solution was incubated at room temperature for 30 min. The supernatant was removed following centrifuging, 0.1 M HCl was added, and the sample was centrifuged again. 0.5 M NaOH was added and the samples were votexed to release the dye. The collagen content was then determined by measuring the absorbance of each sample at a wavelength of 540 nm.
The elastin content was quantified using the Fastin Elastin Assay (Biocolor). Elastin from the dried arteries was solublized by boiling in 0.25 M oxalic acid for 5 h. Elastin in the sample solutions was then precipitated using the manufacturer's precipitating agent. After 10 min the samples were centrifuged, and the supernatant was removed. The Fastin dye solution was then added to the tubes and allowed to bind with the precipitated elastin for 90 min. The samples were centrifuged again, and the unbound dye in the supernatant was removed. A dye dissociating solution was added to release the dye from the walls of the tube. The absorbance at 513 nm of the resulting solution was used to quantify the elastin content of the arteries.
Cathepsin Expression and Activity Measurements Gelatin Zymography
Excised suprarenal aortas were stored on ice in PBS and placed in 50 lL of lysis buffer (20 nM Tris-HCl [pH 7.5], 5 mM ethylene glycol tetraacetic acid [EGTA], 150 mM NaCl, 20 mM b-glycerol phosphate, 10 mM NaF, 1 mM sodium orthovanadate, 1% Triton X-100, and 0.1% Tween 20) with 0.1 mM leupeptin freshly added to stabilize enzymes during electrophoresis. Aortas were homogenized using disposable sample grinders (GE Healthcare), and protein concentrations were obtained by the bisinchoninic acid (BCA) assay (Pierce). Cathepsin zymography was performed as described previously. 21, 53 Briefly, 59 non-reducing loading buffer (0.05% bromophenol blue, 10% SDS, 1.5 M Tris, 50% glycerol) was added to all samples prior to loading. Equal amounts of protein were resolved by 12.5% SDS-polyacrylamide gels containing 0.2% gelatin at 4°C. Gels were removed and enzymes renatured in 65 mM Tris buffer, pH 7.4 with 20% glycerol for three washes at 10 min each. Gels were then incubated in activity buffer (0.1 M sodium phosphate buffer, pH 6.0, 1 mM EDTA, and 2 mM DTT freshly added) for 30 min at room temperature. Then this activity buffer was exchanged for fresh activity buffer and incubated for 18-24 h (overnight) at 37°C. The gels were rinsed twice with deionized water and incubated for 1 h in Coomassie stain (10% acetic acid, 25% isopropanol, 4.5% Coomassie Blue) followed by destaining (10% isopropanol and 10% acetic acid). Gels were scanned using an Imagequant 4010 (GE Healthcare). Images were inverted in Adobe Photoshop and densitometry performed using Scion Image (Scion Corporation).
Immunohistochemistry
Localization of cathepsin K protein expression within the aortic wall was determined by immunohistochemistry of aortas. Aortic arches were snap frozen in OCT embedding medium and stored at 280°C until sectioned. Tissue sections (8 lm thick) were obtained using a Leica CM3050 Cryostat and mounted on glass slides. Sections were fixed in acetone, rinsed with PBS, and then blocked in 3% BSA for an hour. Sections were immunolabeled with primary rabbit-anti cathepsin K antibodies (Santa Cruz) at 4°C overnight at a 1:100 dilution in 1% BSA and then probed with TRITC anti-rabbit fluorescent secondary antibodies (Santa Cruz) at 37°C for an hour at a 1:100 dilution in PBS in the dark. Negative controls were incubated in 1% BSA overnight and the secondary was added as described previously to rule out non-specific binding. Sections were then mounted using DAPI Pro-long gold antifade reagent and imaged using a Nikon TI-E.
Statistical Analysis
Means between groups were compared using unpaired student t tests with significance at p < 0.05.
RESULTS
Arteries from Mice Expressing HIV Proteins Exhibit Endothelial Dysfunction
Isometric relaxation tests on aortic rings exposed to acetylcholine (an endothelial-dependent vasodilator) and SNP (an endothelial-independent vasodilator) were performed to assess endothelial and smooth muscle vaso-regulatory function, respectively. The concentration-relaxation curves of acetylcholine were different between the HIV Tg and wildtype mouse aortic rings, with HIV Tg aortic rings having decreased relaxation (Fig. 1a) . No differences were observed in the concentration-relaxation curves of SNP in the aortas across groups (Fig. 1b) . Thus, the difference in total relaxation (94.84 ± 2.893 and 73 ± 4.780% for WT and HIV Tg respectively, p < 0.05, N = 10 for WT, N = 9 for HIV Tg, Fig. 1c ) is due to endothelial dysfunction.
Arteries from Mice Expressing HIV Proteins Exhibit Altered Arterial Biomechanics, Including Elevated Arterial Stiffness
Cylindrical biaxial biomechanical testing revealed that the common carotid arteries from the HIV Tg mice have a smaller diameter for a given pressure, with statistically significant differences at pressures between 60 and 100 mm Hg (p < 0.05, N = 9) for the in vivo axial stretch (k = 1.7, Fig. 2a ) and subphysiological stretch (k = 1.4, data not shown). No differences were observed in aortic diameters (Fig. 2c) .
HIV Tg arteries exhibited elevated arterial stiffness (as defined by the Peterson's Modulus), compared to wildtype arteries. Differences were seen at pressures between 20 and 60 mmHg for common carotid arteries at the in vivo axial stretch (k = 1.7; Fig. 2b ), as well as at subphysiological (k = 1.4) and superphysiological (k = 1.9) stretches (data not shown). Similarly, differences were seen in aortas of HIV Tg at pressures of 20-40 mm Hg for the in vivo axial stretch (k = 1.7; Fig. 2d ), and at subphysiological (k = 1.4) and superphysiological (k = 1.9) stretches (data not shown). No differences were observed in the axial force during fixed length pressure-diameter tests over physiologically-relevant loads; differences were observed under very low loads (data not shown). No differences were observed in the in vivo axial stretch across groups. There was no difference in the axial force-length behavior of the vessels over physiologically relevant loads; differences were observed at the low stretches and low pressures (data not shown).
Carotid arteries and suprarenal aortas from HIV Tg mice had larger opening angles compared to wildtype arteries (63.7 ± 10.5 vs. 46.2 ± 8.4 for carotid, 139.5 ± 10.4 vs. 83.5 ± 12.5 for aorta, p < 0.05, N = 6, data reported as mean ± SEM, Fig. 3 ). The increased opening angle in the HIV Tg mice indicated there was a greater residual stress in the vessel wall in the unloaded state.
Mice Expressing HIV Proteins show Increased
Carotid Intima-Media Thickness HIV Tg mice show increased c-IMT compared to control mice, confirmed by both the histological and two-photon microscopy methods (Fig. 4) . Microscopy images of the arteries in a loaded state (pressure = 100 mmHg and k = 1.7) revealed an increased medial thickness in the HIV Tg mice for both the suprarenal aorta (31.6 ± 1.7 vs. 17.7 ± 1.3 lm) and carotids (24.3 ± 1.4 vs. 12.3 ± 0.5 lm), and the carotids in the HIV Tg mice also had advential thickening (12.5 ± 0.7 vs. 6.3 ± 0.8 lm) (p < 0.05, N = 6, Fig. 4b ). Note that the value of mean c-IMT measured from fixed tissue was different from that measured with two-photon microscopy as it was in a loaded FIGURE 1. HIV-1 protein expression impairs endothelium-dependent relaxation. Acetylcholine concentration-relaxation curves for contracted aortic rings (a) for HIV Tg and wildtype mice are different while the SNP curves (b) reveal no differences between groups. Thus, the difference in total relaxation (c) (94.84 6 2.893 and 73 6 4.780 for WT and HIV Tg respectively) can be attributed to endothelial dysfunction (asterisk indicates p < 0.05, N 5 10 for WT, N 5 9 for HIV Tg, and data is mean 6 SEM).
configuration while the histology measurements were from fixed unloaded tissue.
Collagen Fiber Angles are Similar Between Groups
Fast Fourier transform techniques were used to calculate the average of fiber angle distribution through the wall (Fig. 5a) ; however, the weighted mean fiber angles for the vessels (a measure of the peak) showed no significant differences in distribution (p < 0.05, N = 6, Fig. 5b ).
Aortas from Mice Expressing HIV Proteins have a Lower Elastin Content
Aortas from the HIV Tg mice had less elastin than the wildtype mice (p < 0.05, N = 6, Fig. 6 ); decreased elastin content from the common carotid arteries was not significant (p = 0.21, N = 9). Similarly a non-significant trend of increased collagen in the HIV Tg mice was found for both the aorta and carotids (p = 0.069, N = 6 and p = 0.18, N = 5 respectively). The decrease in elastin content and trend in increased collagen content align well with the finding that vessels from HIV Tg have increased arterial stiffening.
Aortas from Mice Expressing HIV Proteins Exhibit
Increased Cathepsin K and S Activity
Cathepsins K, S, and V are potent elastases. Zymographical analysis of homogenized aortas from HIV-Tg and wildtype mice showed a significant increase in the activity of extracellular matrix bound cathepsin K (75 and 50 kd) and cathepsin S (32 kd). A 6-fold increase in Cathepsin K activity and a 3-fold Peterson's modulus, E p , of the vessels was used to normalize for differences in vessel geometry (b and d, asterisk indicates p < 0.05, N 5 9, and data is mean 6 SEM). increase in Cathepsin S activity was observed (N = 4, p < 0.05) (Figs. 7a and 7b) . Cathepsin V was decreased in the HIV Tg aortas as compared to the aortas from wildtype mice (N = 3, p < 0.05). Increased cathepsin activity was confirmed via fluorescent immunohistochemistry on aortic arch sections. There was an increase in cathepsin K visualized throughout the intima-media layer of the HIV Tg aorta as seen in bright red (Figs. 7c and 7d ). Increased proteolytic activity by cathepsins supports the finding of decreased elastin in the HIV Tg aortas.
DISCUSSION
Mice Expressing HIV Proteins Exhibit Endothelial Dysfunction and Increased Intima-Media Thickness and Arterial Stiffness
Clinical data clearly show endothelial dysfunction, 3, 31, 43, 45, 47 increased arterial stiffness, 17, 35, 36, [47] [48] [49] and increased c-IMT 12, 14, 28, 30, 31, 47 in HIV patients, which have been attributed both to HAART treatment and HIV infection. 22 The present study corroborates these findings in HIV-Tg mice, suggesting that HIV-1 proteins alone, independent of HAART treatment or HIV infection, may play a role in cellular and tissue level remodeling associated with atherosclerosis. Isometric relaxation tests on aortic rings were used to assess endothelial function in this mouse model and found significant endothelial dysfunction in HIV-Tg aortas. Similar relaxation behaviors of the aortic rings to SNP, a NO donor, revealed the smooth muscle cells of the arterial wall were still functional and responsive to vasodilative stimuli. However, the decreased relaxation in response to acetylcholine, a vasodilator that acts in an endothelium-dependent manner, is indicative of endothelial dysfunction. Healthy endothelial cells play a role, not only in vasodilation, but also in a number of atheroprotective mechanisms within the vessel wall, and dysfunction of the endothelial layer has been associated with the development of atherosclerosis. 15 Thus, this finding suggests that HIV-1 proteins cause impaired endothelial function and may contribute to the development of atherosclerosis.
Lorenz et al., 22 suggest that HIV-1 and HAART are independent mediators of c-IMT. Their studies found that the intima-media thickness of the carotid bifurcation was 24.8% higher in HIV-1 positive/HAARTnaı¨ve patients compared to uninfected controls, but they observed significantly greater intima-media thickness of the carotid bifurcation and the common carotid artery due to HAART treatment in HIV-1 positive subjects, compared to HIV-positive/HAART naı¨ve subjects. Arteries from the HIV-1 Tg mouse exhibited increased intima-media thickness; this finding indicates that HIV-1 proteins alone may play a role in cellular and tissue level remodeling associated with atherosclerosis.
Arterial stiffening is an important clinical marker of CVD and a key predictor of future cardiovascular events.
1 Rigorous mechanical tests on aorta and common carotid arteries from the HIV-TG and wildtype mice revealed that arteries were stiffer in HIV-Tg mice, indicating the HIV proteins alone may play a role in increased stiffness. Also, although HIV-associated immune dysfunction is known to play a role in atherosclerotic development 15 and has been associated FIGURE 4. HIV-1 protein expression increases intima-media thickness. Thickness of the arteries was calculated using crosssectional views from two-photon microscopy stacks of collagen and elastin autofluorescence and histology cross-sections. Panel (a) shows the intima-media thickness calculated from fixed/frozen histological slides stained with H&E and thickness was calculated using ImageJ (asterisk indicates p < 0.05, N 5 6, data is mean 6 SEM). Panel (b) shows the thickness values calculated from cross-sectional views of two-photon microscopy image stacks. The intima-media thickness in both HIV Tg arteries was increased as seen in histology while the adventitia thickness also increased in the HIV Tg carotids only (asterisk indicates p < 0.05, N 5 6, data is mean 6 SEM).
with arterial stiffness in HIV-infected subjects, 17 since this mouse model lacks infected immune cells, it shows that the proteins themselves can mediate the arterial stiffening in this mouse model through mechanisms yet to be determined.
Markers of Vascular Remodeling are Consistent with Early On-Set Atherosclerosis
In addition to providing parallel data to support clinical observations in HIV-patient populations and isolating the role of a single mediator (e.g., HIV proteins) on disease progression, animal models allow for measurements that cannot be obtained from human subjects. Biomechanical analysis revealed that, although differences were observed in the circumferential arterial stiffness in HIV-Tg mice, there were few mechanical differences in the axial direction. Also, observed differences in opening angle suggest differences in the local, in vivo, mechanical environment (i.e., the local stresses) under physiological loads at different locations across the vessel wall. Such differences in the local mechanical environment may provide insights into local differences in mechanically-mediated biological responses.
Vascular remodeling occurs in part by synthesis, proteolytic degradation, and remodeling of key structural components of the arterial wall (e.g., elastin and collagen) and changes in vascular function (e.g., endothelial dysfunction), which can lead to changes in geometric and biomechanical properties of the artery (e.g., c-IMT, and arterial stiffness, respectively). While the differences in collagen were not statistically significant, aortas from HIV Tg mice had significantly less elastin. Loss of functional elastin is often attributed with arterial stiffening and is common with aging, aneurysm development, and atherosclerosis. 8, 20 Thus, the observed decrease in elastin supports the observed increases in arterial stiffness in HIV-Tg mice. The cysteine cathepsin family of proteases in humans and mouse models of atherosclerosis are known to play a key role in vascular remodeling 24, 39, 40 ; cathepsin activity is upregulated in atheroprone regions of the vasculature. 34 Zymography revealed cathepsin K activity in the arterial wall was increased six-fold in the presence of HIV proteins while cathepsin S was increased three-fold. These changes in cathepsin levels (Fig. 7) may occur as the result of impaired NO production and bioavailability ( Fig. 1) and/or pro-inflammatory viral proteins, thereby increasing elastolytic activity and degrading elastin in the arterial wall (Fig. 6 ), leading to maladaptive remodeling that increases arterial stiffness (Fig. 2) , opening angle (Fig. 3) , and c-IMT (Fig. 4) .
Potential Mechanisms: Direct Affect of HIV Proteins on Vascular Cells
This paper presents observational results that expression of HIV proteins leads to geometric, functional, and biomechanical changes that parallel clinical observations in HIV populations. The mechanisms by which HIV proteins lead to such changes, however, remain unknown. HIV-1 has not been shown to infect vascular endothelial cells in vivo; however, it is postulated that in HIV-infected populations endothelial dysfunction may be caused by exposure to circulating infected CD4+T cells and monocytes as well as viral proteins that have been released into the blood. 18, 32, 33 The tat protein, which is actively secreted by infected cells, has been found to have a variety of negative effects on the vasculature. Namely, tat has decreased the ability of pig coronary arteries to dilate by the inhibiting the expression of NO synthase (NOS) and thus NO availability. 32 Exposure of endothelial cells to tat caused the release monocyte chemoattractant protein-1 (MCP-1), which increases adhesion to the endothelium and transendothelial migration of circulating mononuclear cells into the vascular wall. 33 Numerous other studies have found various other effects of tat, gp120, vpu, and nef proteins on endothelial cells including expression of cell adhesion molecules, increased endothelial permeability, cell proliferation, cytokine signaling, apoptosis, and oxidative stress. 18 Therefore, this non-infectious mouse model has a similar phenotype to the altered signaling and function that has been observed in vascular endothelial cells exposed to HIV-1 proteins.
Potential Mechanisms: Secondary Effect of Other Systemic Changes
While there are compelling arguments to suggest that the observed vascular changes may be a direct result of HIV-1 proteins on vascular cells, there are also compelling arguments to suggest that these observations are a secondary effect of other systemic changes, such as end-stage organ disease, dyslipidemia, hypertension, and/or inflammation. For example, Kopp et al. 19 reported that the NL4-3D gag/pol transgenic hemizygous mice develop proteinuria by 4 weeks of age and end-stage renal disease by 14 weeks. Such renal disease and associated hypertension could lead to some of the observed vascular changes reported here.
In summary, while the HIV-Tg mice did not develop atherosclerosis in the time course of this study, they did exhibit several characteristics that are indicative of preclinical atherosclerosis. The HIV-Tg mouse model offers the advantage of isolating the effects of the viral proteins not possible clinically. While data from clinical studies have found that HIV-1 positive patients exhibit early markers of atherosclerosis, some discrepancies still exist between studies due the inability to control other cardiovascular risk factors such as age, gender, weight, cholesterol levels, smoking, and hypertension in all patients as well the confounding effects from HAART therapy. This study isolates the in vivo effects of the HIV-1 proteins in a mouse model without such confounding factors. Whereas in vitro studies have observed some effects such as endothelial dysfunction and monocyte adhesion, 18, 27, 32, 33 those in vitro models do not allow for the study of clinically observed characteristics such as arterial stiffening and thickening. Not withstanding the numerous differences in mouse models compared to humans disease, these findings support the further use of this animal model to investigate mechanisms involved in the progression of HIV-associated atherosclerosis.
